NYSE · WAT
Waters Corporation
Healthcare · Medical - Diagnostics & Research
$460.31▲ 1.46% ($6.64)today
As of 10:03 AM ET
Valuation
Revenue & margin DCF
Verdict: expensive. Price above all scenarios.
The price needs 37.9% revenue growth a year for 10 years. Our scenarios assume 13.9–24.2%.
That's 11.7× its past 4-year pace.
Value per share
Base case
$103.45
Price used $460.31 is 4.4× this
USD · TTM ending Jul 4, 2026 · Price Oct 26, 2:03 PM UTC
Revenue each value needs
Revenue today $4.6B. The price needs $116B by 2036. Base case: $27.4B. At its recent pace: $6.4B. Bear to Bull: $17.1B to $40.5B.
Revenue today $4.6B. The price needs $116B by 2036. Base case: $27.4B. At its recent pace: $6.4B. Bear to Bull: $17.1B to $40.5B.
Revenue in 2036
today $4.6B
+$88.3Bmore than the Base case · 4.2×
Value per share · Base case
$103.45
Price $460.31
4.4× this
- 10-yr revenue CAGR
- 19.4%
- Ending operating margin
- 8.0%
- Discount rate
- 9.2%
USD · TTM ending Jul 4, 2026 · Price Oct 26, 2:03 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 29.49% over the last year. Revenue grew 52.47% over the trailing twelve months. Operating margin moved from 27.69% to 7.96%. Free cash flow declined 35.67% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 7.96%. A decisive move in revenue — currently up 52.47% — would be the clearest signal to resolve the ambiguity.
Return analysis
Company profile
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe.
Market multiples
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
19
Buy
16
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 3, 2026
Q3 FY26 · EPS est $4.00 · Revenue est $1.8B
Same quarter, year over year
FY26 YTD +10.6%Each cell vs the same quarter a year earlier (the cell below) · Q1–Q2 combined $5.75 vs $5.20 · all 2 quarters up
Q1
Q2
Q3
Q4
FY total
FY26
—
—
FY25
FY24
FY23
—
—
—
Fiscal year totals
- FY25
- $13.13
- +10.6%
- FY24
- $11.87
- —
Q2 FY26
Reported Aug 4, 2026 · Latest
HoverTap a cell to inspect
Actual
$3.05
Estimate
$3.01
Year over year
+3.4%
Vs prior quarter
+13.0%
Institutional Sentiment
Waters Corporation · WAT
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.